Julie R Park

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. doi request reprint Children's Oncology Group's 2013 blueprint for research: neuroblastoma
    Julie R Park
    Seattle Children s Hospital, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA 98106, USA
    Pediatr Blood Cancer 60:985-93. 2013
  2. doi request reprint Neuroblastoma: biology, prognosis, and treatment
    Julie R Park
    Division of Hematology and Oncology, University of Washington School of Medicine and Children s Hospital and Regional Medical Center, Seattle, WA 98105 0371, USA
    Pediatr Clin North Am 55:97-120, x. 2008
  3. pmc Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study
    Julie R Park
    Seattle Children s Hospital, 4800 Sandpoint Way NE, Mailstop B6553, Seattle, WA 98105, USA
    J Clin Oncol 29:4351-7. 2011
  4. doi request reprint Neuroblastoma: biology, prognosis, and treatment
    Julie R Park
    Division of Hematology and Oncology, University of Washington School of Medicine and Seattle Children s Hospital, 4800 Sand Point Way NE, Seattle, WA 98105 0371, USA
    Hematol Oncol Clin North Am 24:65-86. 2010
  5. pmc Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group
    Julie R Park
    Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
    Pediatr Blood Cancer 52:44-50. 2009
  6. doi request reprint Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group
    Gregory A Yanik
    Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    J Nucl Med 54:541-8. 2013
  7. ncbi request reprint Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse
    Blythe Thomson
    Seattle Children s Hospital and Regional Medical Center, Seattle, Washington, USA
    Pediatr Blood Cancer 43:571-9. 2004
  8. ncbi request reprint Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation
    Thomas G Gross
    Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, USA
    J Clin Oncol 23:6481-8. 2005
  9. ncbi request reprint Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma
    Scott M Bradfield
    Department of Pediatric Hematology Oncology, Children s Hospital and Regional Medical Center, Seattle, Washington 98105 5371, USA
    Cancer 100:1268-75. 2004
  10. doi request reprint High-risk neuroblastoma: a therapy in evolution
    Abraham Fong
    Seattle Children s Hospital and University of Washington, Department of Pediatrics, Seattle, Washington 98105, USA
    Pediatr Hematol Oncol 26:539-48. 2009

Research Grants

  1. Novel Therapies for High-Risk Neuroblastoma
    Julie Park; Fiscal Year: 2006

Detail Information

Publications17

  1. doi request reprint Children's Oncology Group's 2013 blueprint for research: neuroblastoma
    Julie R Park
    Seattle Children s Hospital, University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, Seattle, WA 98106, USA
    Pediatr Blood Cancer 60:985-93. 2013
    ..Phase 2 trials will investigate druggable target(s) including mTOR inhibition and GD2-directed therapy in combination with chemotherapy for patients with recurrent neuroblastoma, and ALK inhibition for those with ALK-aberrant tumors...
  2. doi request reprint Neuroblastoma: biology, prognosis, and treatment
    Julie R Park
    Division of Hematology and Oncology, University of Washington School of Medicine and Children s Hospital and Regional Medical Center, Seattle, WA 98105 0371, USA
    Pediatr Clin North Am 55:97-120, x. 2008
    ....
  3. pmc Pilot induction regimen incorporating pharmacokinetically guided topotecan for treatment of newly diagnosed high-risk neuroblastoma: a Children's Oncology Group study
    Julie R Park
    Seattle Children s Hospital, 4800 Sandpoint Way NE, Mailstop B6553, Seattle, WA 98105, USA
    J Clin Oncol 29:4351-7. 2011
    ..To assess the feasibility of adding dose-intensive topotecan and cyclophosphamide to induction therapy for newly diagnosed high-risk neuroblastoma (HRNB)...
  4. doi request reprint Neuroblastoma: biology, prognosis, and treatment
    Julie R Park
    Division of Hematology and Oncology, University of Washington School of Medicine and Seattle Children s Hospital, 4800 Sand Point Way NE, Seattle, WA 98105 0371, USA
    Hematol Oncol Clin North Am 24:65-86. 2010
    ....
  5. pmc Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group
    Julie R Park
    Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
    Pediatr Blood Cancer 52:44-50. 2009
    ..The components of therapy required for patients with INSS Stage 3 neuroblastoma and high-risk features remain controversial...
  6. doi request reprint Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group
    Gregory A Yanik
    Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI 48109, USA
    J Nucl Med 54:541-8. 2013
    ..A semiquantitative mIBG score (Curie score [CS]) was assessed for utility as a prognostic indicator for a cohort of patients with high-risk metastatic disease...
  7. ncbi request reprint Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse
    Blythe Thomson
    Seattle Children s Hospital and Regional Medical Center, Seattle, Washington, USA
    Pediatr Blood Cancer 43:571-9. 2004
    ..The ability to achieve a durable second remission is complicated by toxicity and resistant disease. We report a novel combination of chemotherapy for relapsed pediatric ALL...
  8. ncbi request reprint Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation
    Thomas G Gross
    Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE, USA
    J Clin Oncol 23:6481-8. 2005
    ....
  9. ncbi request reprint Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma
    Scott M Bradfield
    Department of Pediatric Hematology Oncology, Children s Hospital and Regional Medical Center, Seattle, Washington 98105 5371, USA
    Cancer 100:1268-75. 2004
    ....
  10. doi request reprint High-risk neuroblastoma: a therapy in evolution
    Abraham Fong
    Seattle Children s Hospital and University of Washington, Department of Pediatrics, Seattle, Washington 98105, USA
    Pediatr Hematol Oncol 26:539-48. 2009
    ..These novel therapies are likely to pose a whole new set of challenges and questions and emphasize the need for continued enrollment of patients in therapeutic studies...
  11. pmc Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation in vitro and in vivo
    Brianne S Raccor
    Department of Pharmacy, University of Washington, Seattle, WA 98195 7610, USA
    Drug Metab Dispos 40:54-63. 2012
    ..Concomitant chemotherapy agents did not influence 4HCY formation in vitro. We conclude that CYP2B6 genotype is not consistently related to 4HCY formation in vitro or in vivo...
  12. doi request reprint Influenza-associated morbidity in children with cancer
    Sarah K Tasian
    Department of Pediatrics, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    Pediatr Blood Cancer 50:983-7. 2008
    ..The clinical impact of influenza in children undergoing therapy for cancer is not well-described in the literature...
  13. pmc Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group
    Jeannine S McCune
    Department of Pharmacy, University of Washington, Box 357630, Seattle, WA 98195 7630, USA
    J Clin Pharmacol 49:88-102. 2009
    ....
  14. ncbi request reprint Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia
    Douglas S Hawkins
    Children s Hospital and Regional Medical Center, Seattle, Washington 98105 0371, USA
    Clin Cancer Res 10:5335-41. 2004
    ....
  15. ncbi request reprint Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases
    Jessica A Wright
    Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington 98105 0371, USA
    J Pediatr Hematol Oncol 25:286-91. 2003
    ..Case series of IA in the pediatric oncology population are limited but generally report poor overall survival...
  16. ncbi request reprint Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma
    Julie R Park
    Department of Pediatric Hematology Oncology, Children s Hospital and Medical Center, Seattle, Washington, USA
    Mol Ther 15:825-33. 2007
    ..This first-in-humans pilot study sets the stage for clinical trials employing adoptive transfer in the context of minimal residual disease...
  17. ncbi request reprint Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients
    Julie R Park
    Pediatric Hematology Oncology, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington, USA
    Med Pediatr Oncol 40:93-8. 2003
    ..Outpatient empiric antibiotic therapy can be safely administered to a subset of febrile neutropenic patients at low risk for clinical complications...

Research Grants1

  1. Novel Therapies for High-Risk Neuroblastoma
    Julie Park; Fiscal Year: 2006
    ..abstract_text> ..